DEA
Easterly Government Properties, Inc.
stock NYSE

I cannot imagine rescheduling not happening although I've never understood why this administration chose to make this a medical/recreational thing.
The next statement comes from the DEA's own website. This rationale is difficult to contest. There are actually facts from the HHS Report embedded in what I consider to be a reasonable assessment:
1. Acceptance of Medical Use in Treatment
* Marijuana no longer meets the Schedule I criteria of having "no currently accepted medical use".
* The federal government recognizes that broad-based data from state programs demonstrates widespread therapeutic use. More than 30,000 practitioners treat upwards of 6 million medical marijuana patients across 43 U.S. jurisdictions, **establishing accepted medical utility for conditions such as anorexia, nausea, and chronic pain.**
2. Reduced Potential for Abuse
* While acknowledging marijuana remains a drug capable of causing harm, its abuse potential is lower than that of Schedule I or Schedule II substances (such as heroin or fentanyl).
* Data indicates that while marijuana is widely consumed, its overall rate of serious adverse health outcomes, high-risk physical addiction, and overdose mortality profile aligns much more consistently with the threshold of Schedule III drugs (which includes substances like ketamine, anabolic steroids, and Tylenol with codeine).
3. Moderate or Low Physical Dependence Risk
* Schedule III requires a drug to carry a low-to-moderate risk of physical dependence or a high risk of psychological dependence.
* Federal medical data concluded that the physical withdrawal and dependence profile associated with chronic cannabis use, while prevalent, does not mirror the severe, physically life-threatening withdrawal symptoms seen in higher-schedule narcotics and depressants.

Sure. The GAO report itself actually underscores that the broader scheduling system functions as intended by the law.
The GAO report explicitly and specifically notes that despite the lack of written internal manuals, the actual scheduling results are consistent. Between 2020 and 2025, the DEA acted on 208 substances. For every single one of the 95 drugs where an HHS evaluation was legally required, the DEA considered it and aligned perfectly with the HHS medical recommendation in every finalized case. Specifically, look at pages 9 and 12-14 of the GAO full report https://www.gao.gov/assets/gao-26-108623.pdf

DEA doesn't get to choose whether to respond. Julius *ordered* the government to file by October 13. Ignoring an order from its own judge would be a remarkable and attention getting step. The DEA will answer.

President Trump ‘Not Happy’ With Marijuana Rescheduling Delays, Plans to Contact Attorney General and DEA Chief, Senior Adviser Says...MH

I highly doubt the DEA is going to respond to this pause in proceedings we are stuck in purgatory yet again It’s a never ending nightmare Don’t want to sell here at bottom Sold my CL on Monday thank god before this crash Just feeling sick right now

I agree. I’m actually only putting it in Kabir’s words. He likes give conservative estimates. I also think the administration could get ahead with this very quickly, which was specifically intended with the EO as well. I actually myself think it’s reasonably likely that FDA decision comes in December. The EO gave order for DEA to start the rescheduling process after phase 3 results, before even NDA, so if they actually do this, it is not impossible to have also rescheduling done by year end. I think Kabir Nath prefers to guide conservatively, because this is not anymore under CMPS control how fast everything goes. Last item that’s under their control is finalizing NDA, and as I said I trust them to deliver in time (which for me is October, and as early as possible in October but they still have to not rush it of course)

Yup, I’m here to kick up rocks again. Please remember, I only vote blue & I live in the super blue state. But I do have to point out the real danger and yes, I’m learning the hard way; Democrats don’t believe the B.S they’re peddling.
My original thesis: Democrats will do everything they can to delay or derail the rescheduling process.
Here’s what A.I found;
I dug into the actual GAO report, and **there is a significant connection to Cory Booker**
**What the GAO report itself says**
The report is **GAO-26-108623, released September 23, 2026**. GAO says the work was conducted from **July 2025 through September 2026** and was done because **members of Congress had raised questions about how DEA handles HHS scientific evaluations and scheduling recommendations.**
It’s me again, LandStander420. Now consider Schumer’s bill CAOA. Which seeks to throw away all progress made during rescheduling, start over, fully legalize, but impose at tax 250X higher than cigarettes and 1000sX higher than alcohol.
What is the timeline on that?? How many years would that put on the clock?
Big investors know this, it isn’t stock manipulation. They’re pulling out because the risk is too high. If they’re looking at 10 years before anything happens, they want their money to grow elsewhere. Yes, we will bleed today. We will continue to bleed.
Other questions to ask; How much lobbying money has Schumer’s family made from Alcohol and Tobacco lobbyists?
You can start your downvotes and snarky comments now.

Just so we are all clear, this stay is due to the concern both HHS and DEA allegedly do not have a formalized scheduling process.
If true, then it potentially invalidates every scheduling, inclusive of marijuana being categorized as S1 in the first place.
I doubt the DOJ wants to open that can of worms…but then, I did not think we would see gas at $5 with this “Drill Baby Drill” President.

I mean the (as they say) the unlikely case that FDA and DEA would act fast enough to allow for BOTH FDA approval and DEA rescheduling finished and commercial launch starded STILL this year. Otherwise getting FDA approval is in my opinion 90+ % likelihood

CMPS is guiding completion of NDA in this quarter q4/2026. You will see that they will actually complete it in this month (October). CEO Kabir Nath has repeatedly said and also just recently, that CMPS will be ready for the unlikely chance of FDA approval plus DEA rescheduling by the end of this year 2026. This does not make any sense if they don’t finalize NDA in October, because otherwise by action of the company itself they would make their promise impossible.

> The DEA administrator was chosen by President Trump. President Trump has decided that marijuana should be S3
Trump promised *medical* rescheduling. That already happened. This is about expanding that beyond medical, something Trump never promised.

I cannot imagine rescheduling not happening although I've never understood why this administration chose to make this a medical/recreational thing.
The next statement comes from the DEA's own website. This rationale is difficult to contest. There are actually facts from the HHS Report embedded in what I consider to be a reasonable assessment:
1. Acceptance of Medical Use in Treatment
* Marijuana no longer meets the Schedule I criteria of having "no currently accepted medical use".
* The federal government recognizes that broad-based data from state programs demonstrates widespread therapeutic use. More than 30,000 practitioners treat upwards of 6 million medical marijuana patients across 43 U.S. jurisdictions, **establishing accepted medical utility for conditions such as anorexia, nausea, and chronic pain.**
2. Reduced Potential for Abuse
* While acknowledging marijuana remains a drug capable of causing harm, its abuse potential is lower than that of Schedule I or Schedule II substances (such as heroin or fentanyl).
* Data indicates that while marijuana is widely consumed, its overall rate of serious adverse health outcomes, high-risk physical addiction, and overdose mortality profile aligns much more consistently with the threshold of Schedule III drugs (which includes substances like ketamine, anabolic steroids, and Tylenol with codeine).
3. Moderate or Low Physical Dependence Risk
* Schedule III requires a drug to carry a low-to-moderate risk of physical dependence or a high risk of psychological dependence.
* Federal medical data concluded that the physical withdrawal and dependence profile associated with chronic cannabis use, while prevalent, does not mirror the severe, physically life-threatening withdrawal symptoms seen in higher-schedule narcotics and depressants.

Sure. The GAO report itself actually underscores that the broader scheduling system functions as intended by the law.
The GAO report explicitly and specifically notes that despite the lack of written internal manuals, the actual scheduling results are consistent. Between 2020 and 2025, the DEA acted on 208 substances. For every single one of the 95 drugs where an HHS evaluation was legally required, the DEA considered it and aligned perfectly with the HHS medical recommendation in every finalized case. Specifically, look at pages 9 and 12-14 of the GAO full report https://www.gao.gov/assets/gao-26-108623.pdf

DEA doesn't get to choose whether to respond. Julius *ordered* the government to file by October 13. Ignoring an order from its own judge would be a remarkable and attention getting step. The DEA will answer.

President Trump ‘Not Happy’ With Marijuana Rescheduling Delays, Plans to Contact Attorney General and DEA Chief, Senior Adviser Says...MH

I highly doubt the DEA is going to respond to this pause in proceedings we are stuck in purgatory yet again It’s a never ending nightmare Don’t want to sell here at bottom Sold my CL on Monday thank god before this crash Just feeling sick right now

I agree. I’m actually only putting it in Kabir’s words. He likes give conservative estimates. I also think the administration could get ahead with this very quickly, which was specifically intended with the EO as well. I actually myself think it’s reasonably likely that FDA decision comes in December. The EO gave order for DEA to start the rescheduling process after phase 3 results, before even NDA, so if they actually do this, it is not impossible to have also rescheduling done by year end. I think Kabir Nath prefers to guide conservatively, because this is not anymore under CMPS control how fast everything goes. Last item that’s under their control is finalizing NDA, and as I said I trust them to deliver in time (which for me is October, and as early as possible in October but they still have to not rush it of course)

Yup, I’m here to kick up rocks again. Please remember, I only vote blue & I live in the super blue state. But I do have to point out the real danger and yes, I’m learning the hard way; Democrats don’t believe the B.S they’re peddling.
My original thesis: Democrats will do everything they can to delay or derail the rescheduling process.
Here’s what A.I found;
I dug into the actual GAO report, and **there is a significant connection to Cory Booker**
**What the GAO report itself says**
The report is **GAO-26-108623, released September 23, 2026**. GAO says the work was conducted from **July 2025 through September 2026** and was done because **members of Congress had raised questions about how DEA handles HHS scientific evaluations and scheduling recommendations.**
It’s me again, LandStander420. Now consider Schumer’s bill CAOA. Which seeks to throw away all progress made during rescheduling, start over, fully legalize, but impose at tax 250X higher than cigarettes and 1000sX higher than alcohol.
What is the timeline on that?? How many years would that put on the clock?
Big investors know this, it isn’t stock manipulation. They’re pulling out because the risk is too high. If they’re looking at 10 years before anything happens, they want their money to grow elsewhere. Yes, we will bleed today. We will continue to bleed.
Other questions to ask; How much lobbying money has Schumer’s family made from Alcohol and Tobacco lobbyists?
You can start your downvotes and snarky comments now.

Just so we are all clear, this stay is due to the concern both HHS and DEA allegedly do not have a formalized scheduling process.
If true, then it potentially invalidates every scheduling, inclusive of marijuana being categorized as S1 in the first place.
I doubt the DOJ wants to open that can of worms…but then, I did not think we would see gas at $5 with this “Drill Baby Drill” President.

I mean the (as they say) the unlikely case that FDA and DEA would act fast enough to allow for BOTH FDA approval and DEA rescheduling finished and commercial launch starded STILL this year. Otherwise getting FDA approval is in my opinion 90+ % likelihood